Matthew Soliman Elected to ANZCCM Committee

We’d like to extend our congratulations to Cann Compounding’s Head of Business and Product Development, Matthew Soliman, on being elected as a Committee Member of the Australia New Zealand College of Cannabinoid Medicine (ANZCCM).

Matthew's appointment reflects his ongoing commitment to advancing safe, evidence-based patient care and supporting healthcare professionals through education and innovation.

We have no doubt that Matthew will bring valuable insight and passion to the Committee, and we look forward to seeing his contributions help shape the future of medicine across Australia and New Zealand.